Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors.
Hamaguchi
Tetsuya
T
Division of Gastrointestinal Oncology, National Cancer Center Hospital, Pharmaceutical Research Laboratories and Pharmaceutical Development, Nippon Kayaku Co Ltd, Tokyo, Japan. thamaguc@ncc.go.jp
Doi
Toshihiko
T
Eguchi-Nakajima
Takako
T
Kato
Ken
K
Yamada
Yasuhide
Y
Shimada
Yasuhiro
Y
Fuse
Nozomu
N
Ohtsu
Atsushi
A
Matsumoto
Shin-ichi
S
Takanashi
Masaya
M
Matsumura
Yasuhiro
Y